Shanghai Junshi Biosciences Co., Ltd. announced that Dr. Zou Jianjun has been appointed as deputy general manager and global research and development president of the Company with effect from 20 April 2022. The term of office of Dr. Zou as deputy general manager and global research and development president of the Company will commence from the date of approval of her appointment at the Board meeting held on 20 April 2022 and expire on the conclusion of the third session of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.74 HKD | -1.01% | -4.86% | -39.61% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.61% | 3.33B | |
+0.82% | 91.94B | |
-3.16% | 38.74B | |
+64.83% | 26.66B | |
-12.60% | 15.32B | |
-5.89% | 13.3B | |
-11.38% | 11.65B | |
+156.85% | 10.37B | |
-49.84% | 10.12B | |
+2.32% | 9.06B |
- Stock Market
- Equities
- 1877 Stock
- News Shanghai Junshi Biosciences Co., Ltd.
- Shanghai Junshi Biosciences Co., Ltd. Appoints Zou Jianjun as Deputy General Manager and Global Research and Development President of the Company with Effect from 20 April 2022